藥品參考
Cabozantinib
Cabozantinib is a medicine in the class oncology. It is used for hepatocellular carcinoma.
- 藥物類別: Oncology
- 用途: hepatocellular carcinoma
最後更新 來源: US FDA label
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Oncology
- ATC 代碼
- L01EX07
- 常見劑型
- 錠劑, 膠囊
- 常見規格
- 20 mg
- 已知交互作用
- 45 (嚴重: 11 · 中度: 27 · 輕微: 7)
- 商品名
- 5
- 國家與市場
- 3
用途
作用方式
Cabozantinib inhibits the tyrosine kinase activity of MET, VEGFR-1, -2 and -3, AXL, RET, ROS1, TYRO3, MER, KIT, TRKB, FLT-3, and TIE-2, receptor kinases involved in oncogenesis, metastasis, tumor angiogenesis and drug resistance.
成人常用劑量（仿單摘要）
Renal cell carcinoma (single agent): 60 mg orally once daily until disease progression or unacceptable toxicity
懷孕與哺乳
- 懷孕
- Unsafe Can cause fetal harm; animal studies showed fetal death and malformations. No human data. Check pregnancy status first; use effective contraception during treatment and for 4 months after the last dose.
- 哺乳
- Unsafe No human milk data. Do not breastfeed during treatment and for 4 months after the last dose.
已通報的副作用
- Diarrhea
- Fatigue
- Palmar-plantar erythrodysesthesia
- Decreased appetite
- Hypertension
- Nausea
哪些人需要特別留意
- Severe and fatal hemorrhage; do not give to patients with recent hemorrhage; withhold 3 weeks before surgery.
- GI perforations and fistulas; monitor and discontinue for Grade 4 fistula or GI perforation.
- Arterial and venous thromboembolic events; discontinue for acute MI or serious events.
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
重要交互作用 (45)
- Apalutamide + Cabozantinib Major
- Cabozantinib + Carbamazepine Major
- Cabozantinib + Clarithromycin Major
- Cabozantinib + Efavirenz Major
- Cabozantinib + Enzalutamide Major
- Cabozantinib + Itraconazole Major
- Cabozantinib + Ketoconazole Major
- Cabozantinib + Nevirapine Major
- Cabozantinib + Phenytoin Major
- Cabozantinib + Posaconazole Major
Pro+ 會員專屬
解鎖完整頁面
建立帳號並開始 Pro+ 試用，即可開啟 Cabozantinib 的完整藥品專論：劑量、懷孕與哺乳、副作用、警示及所有交互作用。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
在網頁版免費試用 Pro+ 14 天，無需信用卡。
同類別的其他藥品
常見問題
What is Cabozantinib used for?
Cabozantinib is a medicine in the class oncology. It is used for Hepatocellular carcinoma, Renal cell carcinoma, Thyroid cancer.
What side effects have been reported with Cabozantinib?
Diarrhea, Fatigue, Palmar-plantar erythrodysesthesia, Decreased appetite, Hypertension, Nausea.
Can Cabozantinib be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Can cause fetal harm; animal studies showed fetal death and malformations. No human data. Check pregnancy status first; use effective contraception during treatment and for 4 months after the last dose. Breastfeeding: Unsafe. No human milk data. Do not breastfeed during treatment and for 4 months after the last dose.
What does Cabozantinib interact with?
MediHelp lists 45 known interactions for Cabozantinib. Major: 11 · Moderate: 27 · Minor: 7. The most serious include Apalutamide, Carbamazepine, Clarithromycin.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
